GDOC Goldman Sachs Future Health Care Equity ETF
The Goldman Sachs Future Health Care Equity ETF (the “Fund”) seeks long-term growth of capital. The fund invests in innovators and disruptors in the healthcare sector by looking for companies that are developing new treatments and technologies, primarily in genomics, precision medicine, tech-enabled procedures, and digital healthcare.
Performance
| 1M | 3M | YTD | 1Y | 3Y ann. | 5Y ann. | |
|---|---|---|---|---|---|---|
| GDOC | +9.6% | +5.5% | +10.7% | +9.4% | +10.9% | +0.3% |
| Equity average (4725 funds) | -2.2% | +2.5% | +85.7% | +59908.1% | +13.6% | +2.3% |
Insider activity in the holdings
Open-market insider buying across this fund’s holdings over 90 days, weighted by holding weight: +$91K net.
Holdings · as of Nov 13, 2026
| # | Holding | Weight |
|---|---|---|
| 1 | LLY ELI LILLY & CO | 14.32% |
| 2 | JNJ JOHNSON & JOHNSON | 6.15% |
| 3 | UNH UNITEDHEALTH GROUP INCORPORATED | 5.66% |
| 4 | MRK MERCK & CO., INC. | 4.83% |
| 5 | EW EDWARDS LIFESCIENCES CORPORATION | 4.72% |
| 6 | VRTX VERTEX PHARMACEUTICALS INCORPORATED | 3.99% |
| 7 | TMO THERMO FISHER SCIENTIFIC INC | 3.86% |
| 8 | A AGILENT TECHNOLOGIES, INC. | 3.83% |
| 9 | AZN.L ASTRAZENECA PLC ORD | 3.36% |
| 10 | GH GUARDANT HEALTH, INC. | 3.29% |
| 11 | DXCM DEXCOM, INC. | 3.22% |
| 12 | GILD GILEAD SCIENCES | 3.07% |
| 13 | ABBV ABBVIE INC. | 2.99% |
| 14 | LONN.SW LONZA GROUP AG | 2.96% |
| 15 | ROIV ROIVANT SCIENCES LTD | 2.83% |
| 16 | COR CENCORA INC | 2.73% |
| 17 | VEEV VEEVA SYSTEMS INC | 2.73% |
| 18 | ISRG INTUITIVE SURGICAL, INC. | 2.60% |
| 19 | MTD METTLER-TOLEDO INTL | 2.01% |
| 20 | RPRX ROYALTY PHARMA PLC | 1.89% |
| 21 | INSM INSMED INCORPORATED | 1.67% |
| 22 | GALD.SW GALDERMA GROUP AG | 1.49% |
| 23 | RGEN REPLIGEN CORP | 1.43% |
| 24 | DGX QUEST DIAGNOSTICS INCORPORATED | 1.40% |
| 25 | BSX BOSTON SCIENTIFIC CORP. | 1.36% |
| 26 | BBIO BRIDGEBIO PHARMA, INC. | 1.36% |
| 27 | CYTK CYTOKINETICS, INC. | 1.23% |
| 28 | NTRA NATERA, INC. | 1.21% |
| 29 | GDOC US DOLLAR | 1.16% |
| 30 | TXG 10X GENOMICS INC | 1.12% |
| 31 | ARGX ARGENX SE-ADR | 1.12% |
| 32 | DNTH DIANTHUS THERAPEUTICS INC | 0.60% |
| 33 | SYRE SPYRE THERAPEUTICS INC | 0.59% |
| 34 | DIM.PA SARTORIUS STEDIM BIOTECH | 0.57% |
| 35 | RYTM RHYTHM PHARMACEUTICALS, INC. | 0.48% |
| 36 | KYMR KYMERA THERAPEUTICS, INC. | 0.45% |
| 37 | PRAX PRAXIS PRECISION MEDICINES, INC. | 0.40% |
| 38 | KARD KARDIGAN, INC. | 0.36% |
| 39 | CGON CG ONCOLOGY, INC. | 0.34% |
| 40 | MDGL MADRIGAL PHARMACEUTICALS INC | 0.32% |
| 41 | DFTX DEFINIUM THERAPEUTICS INC | 0.30% |
Sector breakdown
Country breakdown
Distributions
| Date | Per unit |
|---|---|
| Dec 23, 2025 | $0.1133 |
| Dec 23, 2024 | $0.0058 |
| Dec 26, 2023 | $0.1789 |
| Sep 26, 2022 | $0.0000 |
Members of Congress who disclosed this ETF
No member of Congress has disclosed a trade in GDOC in the filings we hold.
Fund facts, prices, performance and distributions: our market-data vendor. Holdings: the vendor and SEC Form N-PORT. Insider and Congress data: InsiderBuying. Last updated Nov 13, 2026. This is historical data, not investment advice. Report a data error